Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe

Archives of Gerontology and Geriatrics
Luís MidãoElísio Costa

Abstract

Polypharmacy, a common condition among the elderly, is associated with adverse outcomes, including increased healthcare costs, due to higher mortality, falls and hospitalizations rates, adverse drug reactions, drug-drug reactions and medication nonadherence. This study aims to evaluate the prevalence and factors related to polypharmacy in older adults across 17 European countries, plus Israel. In this cross-sectional analysis, we used data from participants aged 65 or more years from Wave 6 of the Survey of Health, Ageing, and Retirement in Europe (SHARE) database. Polypharmacy was defined as the concurrent use of five or more medications. Age, gender, education, physical inactivity, number of limitations with activities of daily living, network satisfaction, quality of life, depression, number of chronic diseases and difficulty taking medication variables were found to be associated with polypharmacy. Our results showed a prevalence of polypharmacy ranging from 26.3 to 39.9%. Switzerland, Croatia and Slovenia were the countries with the lowest prevalence, whereas Portugal, Israel and the Czech Republic were the countries where the prevalence of polypharmacy was the highest. Age, gender, number of limitations with activities of...Continue Reading

Citations

Dec 13, 2018·Expert Opinion on Drug Safety·Jonas W WastessonKristina Johnell
Apr 6, 2019·Geriatrics & Gerontology International·Marta Gutiérrez-ValenciaNicolás Martínez-Velilla
Apr 9, 2019·Geriatrics & Gerontology International·Yi-Ching YangSang-I Lin
Sep 1, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Caroline SiroisValérie Émond
Aug 4, 2020·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Rui BarbosaElísio Costa
Aug 22, 2020·Yearbook of Medical Informatics·Hannah K Galvin, Paul R DeMuro
Sep 3, 2020·Journal of Aging and Health·Carlos A Reyes-OrtizJohn S Luque
Sep 29, 2020·Expert Review of Clinical Pharmacology·Matteo Cesari
Sep 17, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Matthew J WitryKassi Pham
Jun 14, 2019·Aging Clinical and Experimental Research·Pinar KucukdagliMehmet Akif Karan
May 26, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José Alberto Domínguez-AlonsoIgnacio Tusquets
Jun 27, 2020·Therapeutic Advances in Drug Safety·Mina KhezrianPhyo K Myint
Dec 2, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ami VyasMarilyn Barbour
Dec 18, 2019·Drugs -- Real World Outcomes·David SchneggYolanda Mueller
Sep 30, 2020·International Journal of Clinical Practice·Rana K Abu FarhaMohammed Zawiah
Dec 17, 2020·European Journal of Pain : EJP·Aoife O'NeillKieran O'Sullivan
Jan 15, 2021·Geriatrics & Gerontology International·Yoshiki IshibashiMasataka Sasabe
Feb 16, 2021·Frontiers in Pharmacology·Joseph O FadareTosin A Agbesanwa
Dec 6, 2020·Scientific Reports·Yi-An WengChristy Pu
Dec 29, 2020·The Journal of Nutrition, Health & Aging·D Nogueira Paranhos AmorimK H Coelho Vilaça E Silva
Mar 12, 2021·European Geriatric Medicine·Farhad Pazan, Martin Wehling
Apr 4, 2021·International Journal of Environmental Research and Public Health·Luís MidãoElísio Costa
Mar 30, 2021·Journal of Clinical Epidemiology·Annika ViniolNorbert Donner-Banzhoff
Jun 3, 2021·International Journal of Environmental Research and Public Health·Enrica MendittoBernard Vrijens
Jun 3, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·T KogameY Yamamoto
Jun 22, 2021·European Journal of Ageing·Šime SmolićPetra Međimurec
Jul 3, 2021·Pharmacoepidemiology and Drug Safety·Johan Van der HeydenOlivier Bruyère
Jul 27, 2021·Current Epidemiology Reports·Heather E Barry, Carmel M Hughes
Jul 9, 2021·Advanced Drug Delivery Reviews·Christina KaravasiliDimitrios G Fatouros

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.